0001209191-19-023196.txt : 20190403
0001209191-19-023196.hdr.sgml : 20190403
20190403164257
ACCESSION NUMBER: 0001209191-19-023196
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160401
FILED AS OF DATE: 20190403
DATE AS OF CHANGE: 20190403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: During Matthew
CENTRAL INDEX KEY: 0001704631
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 19729586
MAIL ADDRESS:
STREET 1: C/O OVID THERAPEUTICS INC.
STREET 2: 1460 BROADWAY, SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-04-01
0
0001636651
Ovid Therapeutics Inc.
OVID
0001704631
During Matthew
C/O OVID THERAPEUTICS INC.
1460 BROADWAY, SUITE 15044
NEW YORK
NY
10036
1
0
1
0
Stock Option (Right to Buy)
1.76
2019-04-01
4
A
0
75000
0.00
A
2029-03-31
Common Stock
75000
75000
D
25% of the shares will become exercisable immediately and the remaining shares shall vest monthly thereafter over subsequent three years subject to the Reporting Person's continued service through such date.
/s/ Danielle Mann for Matthew During by POA
2019-04-03